Clinical Trials Logo

Clinical Trial Summary

Brief Summary: Background: Feasibility and acceptability of the Carers-ID intervention to improve mental health outcomes in family carers of people with intellectual disabilities. Objective: 1. To conduct a Phase II feasibility randomised controlled trial and process evaluation of the Carers-ID programme. 2. To determine the acceptability of outcome measures of stress, anxiety, depression, resilience and well-being in assessing the impact of the programme on family carers. 3. To determine the recruitment and retention rates of participants in the trial. 4. To identify potential effect sizes and estimate appropriate sample size for use in an effectiveness trial. 5. To determine if progression to a phase III effectiveness trial is warranted. Methodology: Family carers (n = 120) will be randomised to receive the programme (n=60) or assigned to a wait-list control (n=60) group. The intervention (Carers-ID) consists of ten modules which cover topics including: promoting resilience, reducing anxiety, managing stress, accessing local supports, managing family conflict and information for siblings who are carers. Participants (n=12) who have taken part in the intervention arm of the research will be invited to participate in the process evaluation. Outcome: 1. Retention of Subjects in Study Assessments (>80% of family carers) 2. Recruitment of Subjects into Study (>90 carers) 3. Acceptability and feasibility of the outcome measures (>80% of family carers) 4. Depression, Anxiety and Stress Scale - 21; The Warwick-Edinburgh Mental Well-being Scale; The Resilience Scale; and The Social Connectedness Scale Revised. Number of participants to be enrolled: 120 family carers Main inclusion criteria: Participants will be UK adults >18 years of age and will be caring for a family member with an intellectual disability. Statistical Analysis: Descriptive statistics will be used to summarise baseline data including demographic variables and questionnaire responses. Inferential statistics (t-tests or ANOVA) will be used as indicators of difference between the intervention and control arms and will be used to determine effect sizes for sample size calculation in a future phase III trial. Study duration: 24 months


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05737823
Study type Interventional
Source Queen's University, Belfast
Contact Mark Linden, PhD
Phone 028 9097 2233
Email m.linden@qub.ac.uk
Status Recruiting
Phase N/A
Start date May 12, 2023
Completion date March 30, 2025

See also
  Status Clinical Trial Phase
Recruiting NCT05863559 - Super Chef - an Online Program Promoting the Mediterranean Dietary Pattern to Lower Income Families N/A
Completed NCT04169724 - Meditation for Burnout in PA Students N/A
Active, not recruiting NCT04505345 - Virtual Reality Cognitive Training in Alcohol Use Disorder N/A
Completed NCT03286192 - Compassion Cultivation Training for Nurses N/A
Recruiting NCT06322199 - Differences Between Suicide Attempters and Suicide Ideators. Influence of the Brief Therapy Attempted Suicide Short Intervention Program (ASSIP) on Neuropsychological Correlates and Psychological Process Factors - Project 3
Not yet recruiting NCT05790343 - Feasibility Study: Being a Parent - Helping Your Child With Fears and Worries
Terminated NCT05503810 - Social Support Intervention Targeting Patients Treated for Cardiac Disease Who Experience Loneliness N/A
Completed NCT04150354 - Mental Health Symptom Monitoring Utilizing the Cogito Behavioral Analytic Platform N/A
Completed NCT00557869 - Optimization of Cardiac-MR Protocols N/A
Active, not recruiting NCT06175520 - Introduction of Preconception Care Through Public Health System for Improving MNCH&FP N/A
Completed NCT06371248 - Steady Feet: Preventing Falls in the Community N/A
Completed NCT06063252 - Newly Diagnosed With Inflammatory Arthritis - a Self-management Intervention (NISMA) N/A
Terminated NCT03503968 - TCR Modified T Cells MDG1011 in High Risk Myeloid and Lymphoid Neoplasms Phase 1/Phase 2
Not yet recruiting NCT04305990 - Demand-Driven Method for Gas Delivery in a Dental Setting N/A
Completed NCT04553159 - Autologous Adipose Derived Stem Cells Transplantation in the Treatment of Keloids. Phase 2
Completed NCT05697887 - Feasibility, Tolerability and Efficacy of the Ketogenic Diet in Children With Drug-resistant Epilepsy in South Vietnam N/A
Completed NCT03237871 - The EMERGE Project: Feasibility of Assessing Economic and Sexual Risk Behaviors Using Text Messages in Young Adults N/A
Not yet recruiting NCT06087718 - Feasibility of the Maastro Applicator in Rectal Cancer N/A
Active, not recruiting NCT01902238 - EUS-guided Ethanol-lipiodol Ablation of Pancreatic Neuroendocrine Tumor: a Prospective Study N/A
Completed NCT01398059 - The Metabolic Effects of Breaks in Sedentary Time N/A